Letter
Aquaporins in primary Sjögren's syndrome: Comment on the articles by Steinfeld et al
References
- 1
Steinfeld SD,
Demols P,
Salmon I,
Kiss R,
Appelboom T.
Infliximab in patients with primary Sjögren's syndrome: a pilot study.
Arthritis Rheum
2001;
44:
2371–5.
10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 2 Steinfeld SD, Appelboom T, Delporte C. Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002; 46: 2249–51.
- 3 Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 1999; 49: 7–10.
- 4 Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. Scand J Rheumatol 2000; 29: 341–8.
- 5 Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 2001; 34: 123–32.
- 6 Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43: 1647–54.
- 7 Soliven B, Wang N. Tumor necrosis factor-alpha regulates nicotinic responses in mixed cultures of sympathetic neurons and nonneuronal cells. J Neurochem 1995; 64: 883–94.
- 8 Young JA, Cook DI. The major salivary glands. In: R Greger, U Windhorst, editors. Comprehensive human physiology. Vol. 2. Berlin: Springer-Verlag; 1996. p. 1309–26.
- 9 Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152: 5532–9.
- 10 Koski H, Janin A, Humphreys-Beher MG, Sorsa T, Malmstrom M, Konttinen YT. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome. Clin Exp Rheumatol 2001; 19: 131–7.
- 11 Dawson LJ, Christmas SE, Smith PM. An investigation of interactions between the immune system and stimulus-secretion coupling in mouse submandibular acinar cells: a possible mechanism to account for reduced salivary flow rates associated with the onset of Sjogren's syndrome. Rheumatology (Oxford) 2000; 39: 1226–33.
- 12 Steinfeld S, Cogan E, King LS, Agre P, Kiss R, Delporte C. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren's syndrome patients. Lab Invest 2001; 81: 143–8.
- 13 Beroukas D, Hiscock J, Jonsson R, Waterman SA, Gordon TP. Subcellular distribution of aquaporin 5 in salivary glands in primary Sjogren's syndrome. Lancet 2001; 358: 1875–6.
- 14 Waterman SA, Beroukas D, Hiscock J, Jonsson R, Gordon TP. Distribution of salivary aquaporin-5 in Sjögren's syndrome [letter]. Lancet 2002; 359: 1778.
- 15 Beroukas D, Hiscock J, Gannon BJ, Jonsson R, Gordon TP, Waterman SA. Selective downregulation of aquaporin-1 in salivary glands in primary Sjögren's syndrome. Lab Invest 2002; 82: 1547–52.
- 16 Gresz V, Kwon TH, Hurley PT, Varga G, Zelles T, Nielsen S, et al. Identification and localization of aquaporin water channels in human salivary glands. Am J Physiol 2001; 281: G247–54.
- 17 Sato K, Nishiyama A, Kobayashi M. Mechanical properties and functions of the myoepithelium in the eccrine sweat gland. Am J Physiol 1979; 237: C177–84.
- 18 Goldblatt F, Gordon TP, Waterman SA. Autoantibody-mediated intestinal dysmotility in Sjögren's Syndrome. Gastroenterology. 2002; 123: 1144–50.
